國立虎尾科技大學 |

Biopharmaceutical applied statistics symposium.. Volume 2,. Biostatistical analysis of clinical trials

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Biopharmaceutical applied statistics symposium./ edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon.
other author:	Peace, Karl E.
Published:	Singapore :Springer Singapore : : 2018.,
Description:	xiii, 245 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Drugs - Congresses. - Testing -
Online resource:	https://doi.org/10.1007/978-981-10-7826-2
ISBN:	9789811078262

Biopharmaceutical applied statistics symposium.. Volume 2,. Biostatistical analysis of clinical trials
Biopharmaceutical applied statistics symposium.Volume 2,Biostatistical analysis of clinical trials[electronic resource] /edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon. - Singapore :Springer Singapore :2018. - xiii, 245 p. :ill., digital ;24 cm. - ICSA book series in statistics,2199-0980. - ICSA book series in statistics..

On Statistical Approaches to Meta-analysis of Randomized Clinical Trials -- Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies -- Generalized Tests in Clinical Trials -- Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free -- Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia -- Some Statistical Issues in Patient-reported Outcomes -- Network Meta-analysis -- Detecting Safety Signals Among Adverse Events in Clinical Trials -- Applied Meta-analysis using R -- Treatment of Missing Data in Comparative Effectiveness Research -- Missing Data -- Bayesian Subgroup Analysis with Examples -- Statistical Methods in Diagnostic Devices -- A Question-Based Approach to the Analysis of Safety Data -- Analysis of Two-stage Adaptive Seamless Trial Design -- Multiplicity Problems in Clinical Trials - A Regulatory Perspective.

This BASS book Series publishes selected high-quality papers reflecting recent advances in the design and biostatistical analysis of biopharmaceutical experiments - particularly biopharmaceutical clinical trials. The papers were selected from invited presentations at the Biopharmaceutical Applied Statistics Symposium (BASS), which was founded by the first Editor in 1994 and has since become the premier international conference in biopharmaceutical statistics. The primary aims of the BASS are: 1) to raise funding to support graduate students in biostatistics programs, and 2) to provide an opportunity for professionals engaged in pharmaceutical drug research and development to share insights into solving the problems they encounter. The BASS book series is initially divided into three volumes addressing: 1) Design of Clinical Trials; 2) Biostatistical Analysis of Clinical Trials; and 3) Pharmaceutical Applications. This book is the second of the 3-volume book series. The topics covered include: Statistical Approaches to the Meta-analysis of Randomized Clinical Trials, Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies, Generalized Tests in Clinical Trials, Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free , Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia, Selected Statistical Issues in Patient-reported Outcomes, Network Meta-analysis, Detecting Safety Signals Among Adverse Events in Clinical Trials, Applied Meta-analysis Using R, Treatment of Missing Data in Comparative Effectiveness Research, Causal Estimands: A Common Language for Missing Data, Bayesian Subgroup Analysis with Examples, Statistical Methods in Diagnostic Devices, A Question-Based Approach to the Analysis of Safety Data, Analysis of Two-stage Adaptive Seamless Trial Design, and Multiplicity Problems in Clinical Trials - A Regulatory Perspective.

ISBN: 9789811078262

Standard No.: 10.1007/978-981-10-7826-2doiSubjects--Topical Terms:

1208725
Drugs
--Testing--Congresses.

LC Class. No.: RS189 / .B567 2018

Dewey Class. No.: 617.040287

Biopharmaceutical applied statistics symposium.. Volume 2,. Biostatistical analysis of clinical trials
LDR:04182nam a2200349 a 4500 001 928627
003 DE-He213
005 20190304134302.0
006 m d
007 cr nn 008maaau
008 190626s2018 si s 0 eng d
020 $a 9789811078262 $q (electronic bk.)
020 $a 9789811078255 $q (paper)
024 7 $a 10.1007/978-981-10-7826-2 $2 doi
035 $a 978-981-10-7826-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS189 $b .B567 2018
072 7 $a PBT $2 bicssc
072 7 $a MED090000 $2 bisacsh
072 7 $a PBT $2 thema
072 7 $a MBNS $2 thema
082 0 4 $a 617.040287 $2 23
090 $a RS189 $b .B615 2018
245 0 0 $a Biopharmaceutical applied statistics symposium. $n Volume 2, $p Biostatistical analysis of clinical trials $h [electronic resource] / $c edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon.
260 $a Singapore : $c 2018. $b Springer Singapore : $b Imprint: Springer,
300 $a xiii, 245 p. : $b ill., digital ; $c 24 cm.
490 1 $a ICSA book series in statistics, $x 2199-0980
505 0 $a On Statistical Approaches to Meta-analysis of Randomized Clinical Trials -- Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies -- Generalized Tests in Clinical Trials -- Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free -- Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia -- Some Statistical Issues in Patient-reported Outcomes -- Network Meta-analysis -- Detecting Safety Signals Among Adverse Events in Clinical Trials -- Applied Meta-analysis using R -- Treatment of Missing Data in Comparative Effectiveness Research -- Missing Data -- Bayesian Subgroup Analysis with Examples -- Statistical Methods in Diagnostic Devices -- A Question-Based Approach to the Analysis of Safety Data -- Analysis of Two-stage Adaptive Seamless Trial Design -- Multiplicity Problems in Clinical Trials - A Regulatory Perspective.
520 $a This BASS book Series publishes selected high-quality papers reflecting recent advances in the design and biostatistical analysis of biopharmaceutical experiments - particularly biopharmaceutical clinical trials. The papers were selected from invited presentations at the Biopharmaceutical Applied Statistics Symposium (BASS), which was founded by the first Editor in 1994 and has since become the premier international conference in biopharmaceutical statistics. The primary aims of the BASS are: 1) to raise funding to support graduate students in biostatistics programs, and 2) to provide an opportunity for professionals engaged in pharmaceutical drug research and development to share insights into solving the problems they encounter. The BASS book series is initially divided into three volumes addressing: 1) Design of Clinical Trials; 2) Biostatistical Analysis of Clinical Trials; and 3) Pharmaceutical Applications. This book is the second of the 3-volume book series. The topics covered include: Statistical Approaches to the Meta-analysis of Randomized Clinical Trials, Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies, Generalized Tests in Clinical Trials, Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free , Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia, Selected Statistical Issues in Patient-reported Outcomes, Network Meta-analysis, Detecting Safety Signals Among Adverse Events in Clinical Trials, Applied Meta-analysis Using R, Treatment of Missing Data in Comparative Effectiveness Research, Causal Estimands: A Common Language for Missing Data, Bayesian Subgroup Analysis with Examples, Statistical Methods in Diagnostic Devices, A Question-Based Approach to the Analysis of Safety Data, Analysis of Two-stage Adaptive Seamless Trial Design, and Multiplicity Problems in Clinical Trials - A Regulatory Perspective.
650 0 $a Drugs $x Testing $x Statistical methods $v Congresses. $3 1208725
650 0 $a Biopharmaceutics $v Congresses. $3 1208726
650 1 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 670172
650 2 4 $a Biostatistics. $3 783654
700 1 $a Peace, Karl E. $3 1132099
700 1 $a Chen, Ding-Geng. $3 848229
700 1 $a Menon, Sandeep. $3 1208724
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a ICSA book series in statistics. $3 1067975
856 4 0 $u https://doi.org/10.1007/978-981-10-7826-2
950 $a Mathematics and Statistics (Springer-11649)